Birdwatch Archive

Birdwatch Note Rating

2024-05-06 14:22:17 UTC - NOT_HELPFUL

Rated by Participant: 6426D83BD950AD29DD2ED914B061DB37C999E81BD378673D16FFF665D0DB3D1C
Participant Details

Original Note:

The revocation was made at the request of AstraZeneca itself: "At the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) of 29 January 2021 for the medicinal product "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])" is withdrawn." https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf

All Note Details

Original Tweet

All Information

  • noteId - 1787462211700506957
  • participantId -
  • raterParticipantId - 6426D83BD950AD29DD2ED914B061DB37C999E81BD378673D16FFF665D0DB3D1C
  • createdAtMillis - 1715005337906
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 17874622117005069576426D83BD950AD29DD2ED914B061DB37C999E81BD378673D16FFF665D0DB3D1C